ReviewPharmaceutics2023

Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging.

Andrea Rodríguez-Agustín et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.